Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.
Hermsen CC, Verhage DF, Telgt DS, Teelen K, Bousema JT, Roestenberg M, Bolad A, Berzins K, Corradin G, Leroy O, Theisen M, Sauerwein RW. Hermsen CC, et al. Among authors: corradin g. Vaccine. 2007 Apr 12;25(15):2930-40. doi: 10.1016/j.vaccine.2006.06.081. Epub 2006 Aug 2. Vaccine. 2007. PMID: 16914240 Clinical Trial.
Immunogenicity of a recombinant fusion construct composed of intrinsically unstructured, low polymorphic segments derived from merozoite surface protein 2 and trophozoite exported protein 1.
Tiendrebeogo RW, Spallek R, Oehlmann W, Singh M, Theisen M, Nebie I, Moret R, Roussilhon C, Corradin G. Tiendrebeogo RW, et al. Among authors: corradin g. Vaccine. 2019 Aug 23;37(36):5332-5340. doi: 10.1016/j.vaccine.2019.07.048. Epub 2019 Jul 26. Vaccine. 2019. PMID: 31358409
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Steiner-Monard V, Kamaka K, Karoui O, Roethlisberger S, Audran R, Daubenberger C, Fayet-Mello A, Erdmann-Voisin A, Felger I, Geiger K, Govender L, Houard S, Huber E, Mayor C, Mkindi C, Portevin D, Rusch S, Schmidlin S, Tiendrebeogo RW, Theisen M, Thierry AC, Vallotton L, Corradin G, Leroy O, Abdulla S, Shekalaghe S, Genton B, Spertini F, Jongo SA. Steiner-Monard V, et al. Among authors: corradin g. Clin Infect Dis. 2019 Jan 18;68(3):466-474. doi: 10.1093/cid/ciy514. Clin Infect Dis. 2019. PMID: 29945169 Clinical Trial.
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity.
Theisen M, Dodoo D, Toure-Balde A, Soe S, Corradin G, Koram KK, Kurtzhals JA, Hviid L, Theander T, Akanmori B, Ndiaye M, Druilhe P. Theisen M, et al. Among authors: corradin g. Infect Immun. 2001 Sep;69(9):5223-9. doi: 10.1128/IAI.69.9.5223-5229.2001. Infect Immun. 2001. PMID: 11500389 Free PMC article.
Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
Nebie I, Tiono AB, Diallo DA, Samandoulougou S, Diarra A, Konate AT, Cuzin-Ouattara N, Theisen M, Corradin G, Cousens S, Ouattara AS, Ilboudo-Sanogo E, Sirima BS. Nebie I, et al. Among authors: corradin g. Trop Med Int Health. 2008 Feb;13(2):229-37. doi: 10.1111/j.1365-3156.2007.01994.x. Trop Med Int Health. 2008. PMID: 18304269 Free article.
254 results